| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.02 |